IMHDF yields 2.08% · PFE yields 6.13%● Live data
📍 IMHDF pulled ahead of the other in Year 1
Combined, IMHDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IMHDF + PFE for your $10,000?
Isetan Mitsukoshi Holdings Ltd., together with its subsidiaries, engages in the department store business in Japan and internationally. The company operates through Department Store Business, Credit & Finance Business/Customer Organization Management Business, Real Estate Business, and Other Business segments. It is involved in the credit card, insurance, and other businesses; constructs and manages underground garages, public underground passages, and underground shopping malls; leases shops; operates restaurants; operates shares and business management; and construction and design, construction management, renovation and interior furniture, building maintenance, and environment production businesses. The company also engages in the supermarket, retail, and specialty shops; food production; wholesaling business; the operation of airport-style duty free shops; and provision of personnel, employment agency, recruitment office, education and training, and labor and welfare services, as well as information systems solutions. In addition, it plans, develops, imports, and sells gifts, novelty, and lifestyle goods; imports and wholesales western wine and spirits, foods, and miscellaneous products; and sells foodstuffs, clothing, and other daily goods. Further, the company plans, produces, promotes, and sells commercials, video signs, TV programs, movies, plays, entertainment and fashion shows, parties, etc.; engages in advertising agency business; plans and sells travel products and conducts tours; and owns and operates river cruise ships. The company was incorporated in 2008 and is headquartered in Tokyo, Japan.
Full IMHDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.